Editorial board disclosure policy

(Last updated April 2021)
All editors responsible for recommending or making publication decisions are requested to disclose on an annual basis any potential conflict of interest, including current or recent financial relationships with any commercial entity whose products or services may be contained in the journal content.
The following competing interests were disclosed:
Professor Márta Korbonits
Professor Korbonits has received grant and consultancy fees from ONO, Crinetics, Novo & Ipsen.
Dr Robert Clarke
Dr Clarke is a paid consultant for Bayer Pharmaceuticals (less than $10,000) and American Gene Technologies (stock options less than $10,000).
Dr Judith Favier
Dr Favier holds the patents 18,306,527.5 and EP2019/081848 on 'Methods for predicting metastatic potential in patients suffering from sdhb-mutated paraganglioma'.
Professor Wouter de Herder
Professor de Herder has received speaker fees from Novartis-AAA, Pfizer and Ipsen, as well as financial research support from Ipsen and AAA-Novartis.
Professor Chris J McCabe
Professor McCabe is current Chair of the Wellcome Trust Basic Science Interview Committee and has received research grants from MRC, NIHR and Wellcome. He has also received Script consultancy for various medical/scientific TV shows.
Professor Deborah Marsh
Professor Marsh has intellectual property including EP2638394 B1, 'Histone protein ubiquitination as a cancer biomarker'.
Dr Joanne Ngeow
Dr Ngeow is the recipient of research grants from AstraZeneca.
Professor Constantine Stratakis
Professor Stratakis has received research funding from Pfizer, Inc. and Sterotherapeutics, LLC. He has also received employment and editorial fees from Molecular & Cellular Endocrinology and Hormone & Metabolic Research of which he holds editorial positions. He holds patents on the function and/or mutations of the PRKAR1A, PDE11A and GPR101 genes.
The following editor reported no competing interests:
  • Professor Antonio Di Cristofano
  • Professor Paramita Ghosh
Bioscientifica staff and freelancers working on the journal reported no conflicts of interest. Article authors' declarations are stated in each journal article. Referees must disclose any competing interests before agreeing to review any submission. For more information on the journal’s ethical policy, please read the ethical guidelines.
This policy follows the recommendations of the International Committee of Medical Journals Editors (ICMJE) and the Committee on Publication Ethics (COPE).